12 February 2013 -- Joining London Mayor Boris Johnson this morning as he opened the London Stock Exchange to promote the city as a destination for investment in technology and life science, Steve Bates, BIA Chief Executive Officer, said:
"Following AIM listed BIA member, e-Therapeutics announcing a £40 million fundraising to support their drug discovery and development activities into 2017 it is good to have the active support of London Mayor Boris Johnson backing UK biotech. Biotech is a growing sector which has the potential to deliver jobs and growth in the UK, as well as returns for investors."
For further information, please contact Robert Winder, Head of Communications, firstname.lastname@example.org, 020 7630 2191; mobile 07825 942 934.
Picture of the LSE opening ceremony available from http://bit.ly/BIA_Boris Steve Bates is at right of picture.
Video of Boris Johnson on CNBC speaking about investing in London: http://bit.ly/Boris_CNBC
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org